Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition

Oncology Reports

Volumn 34, Issue 2, 2015, Pages 610-616

  Zhou, Chuang ^a   Zheng, Yan ^b   Li, Lin ^c   Zhai, Wenlong ^a   Li, Renfeng ^a   Liang, Zhiwen ^a   Zhao, Longshuan ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c ZHENGZHOU CHILDREN S HOSPITAL   (China)

Author keywords

Adrenomedullin; Epithelial mesenchymal transition; Intrahepatic cholangiocellular carcinoma

Indexed keywords

ADRENOMEDULLIN; NERVE CELL ADHESION MOLECULE; PROTEIN ZO1; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN; VIMENTIN; ADM PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENICITY; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIVER CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL PREDICTION; TISSUE MICROARRAY; TRANSCRIPTION INITIATION; TUMOR INVASION; UPREGULATION; BILE DUCT TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELL LINE; VERY ELDERLY;

ADRENOMEDULLIN; ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84931398882     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4034     Document Type: Article

References (23)

1. Patel T: Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 33: 1353-1357, 2001.
2. Razumilava N and Gores GJ: Cholangiocarcinoma. Lancet 383: 2168-2179, 2014.
3. Rizvi S and Gores GJ: Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145: 1215-1229, 2013.
4. Shaib Y and El-Serag HB: The epidemiology of cholangiocarcinoma. Semin Liver Dis 24: 115-125, 2004.
5. Pascher A, Jonas S and Neuhaus P: Intrahepatic cholangiocarcinoma: Indication for transplantation. J Hepatobiliary Pancreat Surg 10: 282-287, 2003.
6. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H and Eto T: Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192: 553-560, 1993.
7. Martínez A, Vos M, Guédez L, Kaur G, Chen Z, Garayoa M, Pío R, Moody T, Stetler-Stevenson WG, Kleinman HK, et al: The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst 94: 1226-1237, 2002.
8. Ramachandran V, Arumugam T, Hwang RF, Greenson JK, Simeone DM and Logsdon CD: Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Res 67: 2666-2675, 2007.
9. Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K, Figarella-Branger D, Martin PM, et al: Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells. Oncogene 27: 506-518, 2008.
10. Zhu HT, Dong QZ, Wang G, Zhou HJ, Ren N, Jia HL, Ye QH and Qin LX: Identification of suitable reference genes for qRT-PCR analysis of circulating microRNAs in hepatitis B virus-infected patients. Mol Biotechnol 50: 49-56, 2012.
11. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008.
12. Simon R, Mirlacher M and Sauter G: Tissue microarrays. Biotechniques 36: 98-105, 2004.
13. Zhou H, Huang H, Shi J, Zhao Y, Dong Q, Jia H, Liu Y, Ye Q, Sun H, Zhu X, et al: Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection. Gut 59: 1699-1708, 2010.
14. Aggarwal G, Ramachandran V, Javeed N, Arumugam T, Dutta S, Klee GG, Klee EW, Smyrk TC, Bamlet W, Han JJ, et al: Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β scells and mice. Gastroenterology 143: 1510-1517, 2012.
15. Chen P, Huang Y, Bong R, Ding Y, Song N, Wang X, Song X and Luo Y: Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner. Clin Cancer Res 17: 7230-7239, 2011.
16. Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, et al: EMT and dissemination precede pancreatic tumor formation. Cell 148: 349-361, 2012.
17. Ding W, You H, Dang H, LeBlanc F, Galicia V, Lu SC, Stiles B and Rountree CB: Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology 52: 945-953, 2010.
18. El Khatib M, Kalnytska A, Palagani V, Kossatz U, Manns MP, Malek NP, Wilkens L and Plentz RR: Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma. Hepatology 57: 1035-1045, 2013.
19. Oishi N, Kumar MR, Roessler S, Ji J, Forgues M, Budhu A, Zhao X, Andersen JB, Ye QH, Jia HL, et al: Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 56: 1792-1803, 2012.
20. Park SC, Yoon JH, Lee JH, Yu SJ, Myung SJ, Kim W, Gwak GY, Lee SH, Lee SM, Jang JJ, et al: Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth. Cancer Lett 271: 314-322, 2008.
21. Nakata T, Seki N, Miwa S, Kobayashi A, Soeda J, Nimura Y, Kawasaki S and Miyagawa S: Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: Multicentric occurrence or intrahepatic metastasis? Hepatogastroenterology 55: 865-872, 2008.
22. Sánchez-Tilló E, Siles L, de Barrios O, Cuatrecasas M, Vaquero EC, Castells A and Postigo A: Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J Cancer Res 1: 897-912, 2011.
23. Joseph JV, Conroy S, Tomar T, Eggens-Meijer E, Bhat K, Copray S, Walenkamp AM, Boddeke E, Balasubramanyian V, Wagemakers M, et al: TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion. Cell Death Dis 5: e1443, 2014.